MGMT and glioblastoma: Still, hypermethylation of O6-methylguanine DNA methyltransferase (MGMT) predicted increased sensitivity to temozolomide and radiation and isocitrate dehydrogenase-1 mutation (IDH1-R132H), which was a known biomarker in GBM [104].